Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ovarian Cancer: Biomarkers and Targeted Therapy
Mihaela Radu, Alina Prădatu, Florentina Duică, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 693-693
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

The role of gut microbiome in cancer genesis and cancer prevention
Noor Akbar, Naveed Ahmed Khan, Jibran Sualeh Muhammad, et al.
Health Sciences Review (2022) Vol. 2, pp. 100010-100010
Open Access | Times Cited: 41
High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential
Lu Wang, Ji Zhang, Min Xia, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 11, pp. 4414-4431
Open Access | Times Cited: 38
Biomarkers in Ovarian Cancer: Towards Personalized Medicine
Carlos López-Portugués, María Montes‐Bayón, Paula Díez
Proteomes (2024) Vol. 12, Iss. 1, pp. 8-8
Open Access | Times Cited: 8
Targeting NaPi2b in ovarian cancer
Susana Banerjee, Ronny Drapkin, Debra L. Richardson, et al.
Cancer Treatment Reviews (2022) Vol. 112, pp. 102489-102489
Closed Access | Times Cited: 27
Precision medicine in gynecological cancer (Review)
Aikaterini Aravantinou‐Fatorou, Vasiliki Georgakopoulou, Meletios Α. Dimopoulos, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access
Cáncer de ovario
Miriam García Gómez, Pedro Pérez Segura
Medicine - Programa de Formación Médica Continuada Acreditado (2025) Vol. 14, Iss. 24, pp. 1423-1431
Closed Access
Navigating Metabolic Challenges in Ovarian Cancer: Insights and Innovations in Drug Repurposing
Sara Mikhael, Georges Daoud
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access
Deciphering the transcriptional alterations in high grade serous ovarian cancer upon catalytic inactivation of protein kinase D
Komal Tyagi, Priyanka Jain, Adhiraj Roy, et al.
International Journal of Biological Macromolecules (2025), pp. 141699-141699
Closed Access
Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components
Militsa Rakina, Анна Казакова, А. Б. Виллерт, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6215-6215
Open Access | Times Cited: 26
Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy
Laura M. Harbin, Holly H. Gallion, Derek B. Allison, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 842-842
Open Access | Times Cited: 24
Developments in Genetics: Better Management of Ovarian Cancer Patients
Ovidiu Maioru, Viorica-Elena Rădoi, Madalin-Codrut Coman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15987-15987
Open Access | Times Cited: 14
Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells
Hinanit Koltai, Nurit Shalev
Cancers (2022) Vol. 14, Iss. 17, pp. 4299-4299
Open Access | Times Cited: 19
RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter
Huijuan Wu, Liangbin Xia, Lu Sun, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 3
Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
Fahmy T. Ali, Reham M. Soliman, Nahla S. Hassan, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0272308-e0272308
Open Access | Times Cited: 16
Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer
Nan Li, Kai Yu, Delun Huang, et al.
Biological Trace Element Research (2023) Vol. 202, Iss. 4, pp. 1428-1445
Closed Access | Times Cited: 9
IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m6A‐dependent manner
Yaqian Shi, Xueyou Xiong, Yu Sun, et al.
The FASEB Journal (2023) Vol. 37, Iss. 10
Closed Access | Times Cited: 8
SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer
Laura M. Harbin, Nan Lin, Frederick R. Ueland, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14212-14212
Open Access | Times Cited: 8
TRIM8 promotes ovarian cancer proliferation and migration by targeting VDAC2 for ubiquitination and degradation
Fei Wu, Jiaqi Xu, Xin Jin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 11
Open Access | Times Cited: 2
Microbe-material hybrids for therapeutic applications
Meng Chen, Lili Xia, Chenyao Wu, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 16, pp. 8306-8378
Closed Access | Times Cited: 2
Developments in Genetics – a Better Management of Ovarian Cancer Patients
Ovidiu Maioru, Viorica Rădoi, Laurenţiu Camil Bohîlţea, et al.
(2023)
Open Access | Times Cited: 7
Improving the physicochemical and pharmacokinetic properties of olaparib through cocrystallization strategy
Xia-Lin Dai, Bowen Pang, Wenting Lv, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123497-123497
Closed Access | Times Cited: 7
Social, Genetics and Histopathological Factors Related to Titin (TTN) Gene Mutation and Survival in Women with Ovarian Serous Cystadenocarcinoma: Bioinformatics Analysis
Fabiana de Campos Gomes, Eric Renato Lima Figueiredo, Ediane Nunes de Araújo, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1092-1092
Open Access | Times Cited: 6
Phthalimide‐tethered isatins as novel poly(ADP‐ribose) polymerase inhibitors: Design, synthesis, biological evaluations, and molecular modeling investigations
Mahmoud A. El Hassab, Amer Ali Abd El‐Hafeez, Hadia Almahli, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 5
Biomarkers for Early Detection of Ovarian Cancer: A Review
Devarajappa Gari Bindu, Kopparapu Venkata Nanda Kumar, Kasireddy Likitha Reddy, et al.
Asian Pacific Journal of Cancer Biology (2024) Vol. 9, Iss. 1, pp. 81-85
Open Access | Times Cited: 1
Current advances of anticancer drugs based on solubilization technology
Min Wu, Liping Wang, Xiaofang Li, et al.
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top